# Baldwin Insurance Group, Inc.: Form 10-Q for the period ended Sep 30, 2020

- Company: [Baldwin Insurance Group, Inc.](/companies/bwin.md) (CIK 1781755)
- Form: 10-Q
- Filed: 2020-11-12
- Accepted by EDGAR: Nov 12, 2020, 16:17 ET
- Period: 2020-09-30
- Accession: 0001781755-20-000076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781755/000178175520000076/brp-20200930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781755/000178175520000076/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | −$6.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | −$8.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-30 | $12.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$3.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$5.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.22 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $30.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $4.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-09-30 | $50.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $159.1m | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $722.8m | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $124.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $306.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-09-30 | $223.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 63,612 characters.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and the Annual Report on Form 10-K. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part II, Item 1A. Risk Factors and Note Regarding Forward-Looking Statements included elsewhere in this Quarterly Report on Form 10-Q and in the Annual Report on Form 10-K.

### THE COMPANY

BRP Group, Inc. (“BRP Group,” the “Company,” “we,” “us” or “our”) is a rapidly growing independent insurance distribution firm delivering solutions that give our Clients the peace of mind to pursue their purpose, passion and dreams. We support our Clients, Colleagues, Insurance Company Partners and communities through the deployment of vanguard resources and capital to drive organic and inorganic growth. We are innovating the industry by taking a holistic and tailored approach to risk management, insurance and employee benefits. Our growth plan includes increased geographic representation across the U.S., expanded client value propositions and new lines of insurance to meet the needs of evolving lifestyles, business risks and healthcare funding. We are a destination employer supported by an award-winning culture, powered by exceptional people and fueled by industry-leading growth and innovation.

We represent over 500,000 Clients across the United States and internationally. Our more than 800 Colleagues include approximately 250 Risk Advisors, who are fiercely independent, relentlessly competitive and “insurance geeks.” We have over 50 offices, all of which are equipped to provide diversified products and services to empower our clients at every stage through our four Operating Groups.

- **Middle Market** provides expertly-designed private risk management, commercial risk management and employee benefits solutions for mid-to-large-size businesses and high net worth individuals, as well as their families.
- **MainStreet** offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities.
- **Medicare** offers consultation for government assistance programs and solutions to seniors and Medicare-eligible individuals through a network of agents.
- **Specialty** delivers specialty insurers, professionals, individuals and niche industry businesses expanded access to exclusive specialty markets, capabilities and programs requiring complex underwriting and placement.

In 2011, we adopted the “Azimuth” as our corporate constitution. Named after a historical navigation tool used to find “true north,” the Azimuth asserts our core values, business basics and stakeholder promises. The ideals encompassed by the Azimuth support our mission to deliver indispensable, tailored insurance and risk management insights and solutions to our clients. We strive to be regarded as the preeminent insurance advisory firm fueled by relationships, powered by people and exemplified by client adoption and loyalty. This type of environment is upheld by the distinct vernacular we use to describe our services and culture. We are a firm, instead of an agency; we have Colleagues, instead of employees; we have Risk Advisors, instead of producers/agents. We serve clients instead of customers and we refer to our acquisitions as Partnerships. We refer to insurance brokerages that we have acquired, or in the case of asset acquisitions, the producers, as Partners.

The insurance brokerage market is seasonal and our results of operations are somewhat affected by seasonal trends. Our Adjusted EBITDA and Adjusted EBITDA Margins are typically highest in the first quarter and lowest in the fourth quarter. This variation is primarily due to fluctuations in our revenues, while overhead remains consistent throughout the year. Our revenues are generally highest in the first quarter due to the impact of contingent payments received in the first quarter from Insurance Company Partners that we cannot readily estimate before receipt without the risk of significant reversal and a higher degree of first quarter policy commencements and renewals in Medicare and certain Middle Market lines of business such as employee benefits and commercial. In addition, a higher proportion of our first quarter revenue is derived from our highest margin businesses. As discussed further below, the COVID-19 pandemic may skew these general trends due to reduced amounts of new business and reductions in business from existing Clients related to the pandemic.

Partnerships can significantly impact Adjusted EBITDA and Adjusted EBITDA Margins in a given year and may increase the amount of seasonality within the business, especially results attributable to Partnerships that have not been fully integrated into our business or owned by us for a full year.

On June 29, 2020, we completed a public offering of 13,225,000 shares of our Class A common stock, including 1,725,000 shares sold pursuant to the underwriters’ over-allotment option. The shares were sold at an offering price of $13.25 per share for net proceeds of $166.5 million after deducting underwriting discounts and commissions of $7.9 million and offering expenses of $798,000.

### PARTNERSHIPS

We utilize strategic acquisitions, which we refer to as Partnerships, to complement and expand our business. The financial impact of Partnerships may affect the comparability of our results from period to period. Our acquisition strategy also entails certain risks, including the risks that we may not be able to successfully source, close, integrate and effectively manage businesses that we acquire. To mitigate that risk, we have a professional team focused on finding new Partners and integrating new Partnerships. We plan to execute on numerous Partnerships annually as it is a key pillar in our long-term growth strategy over the next ten years.

We completed 11 Partnerships for an aggregate purchase price of $317.7 million during the nine months ended September 30, 2020 and six Partnerships for an aggregate purchase price of $174.1 million during the nine months ended September 30, 2019. Partnerships completed during 2020 added $26.8 million of premiums, commissions and fees receivable, $123.6 million of intangible assets and $179.9 million of goodwill to the condensed consolidated balance sheet. We borrowed an additional $185.6 million under the revolving credit commitment (the “Revolving Credit Commitment”) of the Old JPM Credit Agreement to assist with funding acquisitions during 2020.

For additional information on the Partnerships that we have completed during 2020, see Note 3 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report.

On November 5, 2020, we announced that we have entered into an agreement to acquire all of the outstanding equity interests of Insgroup, Inc. (“Insgroup”). The Partnership is expected to close on November 30, 2020, subject to certain closing conditions.

### NOVEL CORONAVIRUS (COVID-19)

In March 2020, the World Health Organization declared a novel strain of the coronavirus, COVID-19, a pandemic. This COVID-19 outbreak has become increasingly widespread and severely restricted the level of economic activity around the world. In response to this outbreak, the governments of many countries, states, cities and other geographic regions, including in the United States, have taken preventive or protective actions, such as imposing restrictions on travel and business operations and advising or requiring individuals to limit or forgo their time outside of their homes. In the United States, temporary closures of businesses have been ordered and numerous other businesses have temporarily closed voluntarily.

Our Clients and Colleagues are our first priority and we have taken steps to ensure their safety by implementing a remote work environment for the majority of our Colleagues without disruption to Client service. We have funded the BRP True North Colleague Fund to assist with relief for COVID-19 and other qualifying disasters for our Colleagues experiencing extraordinary hardship and are currently matching Colleague donations dollar-for dollar.

We intend to continue to execute on our strategic plans and operational initiatives during the pandemic. However, given the uncertainty regarding the spread and severity of COVID-19, the duration and scope of the government shutdowns, the nature of societal responses and the adverse effects on the national and global economy, the related financial impact on our business cannot be accurately predicted at this time. The national and global economies have rapidly contracted as a result of COVID-19. The decreased level of economic activity is leading to, and is likely to continue to lead to, a decline in exposure units and rising unemployment. In addition, the uncertainties associated with the protective and preventive measures being put in place or recommended by both governmental entities and other businesses, among other uncertainties, may result in delays or modifications to our plans and initiatives. See Part II, Item 1A. “Risk Factors - The ongoing novel coronavirus (COVID-19) pandemic could result in declines in business and increases in claims that could adversely affect our business, financial condition and results of operations” in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020.

### RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements for the three and nine months ended September 30, 2020 and the related notes and other financial information included elsewhere in this report. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2019 and Part II, Item 1A. Risk Factors in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020.

The following is a discussion of our consolidated results of operations for each of the three and nine months ended September 30, 2020 and 2019.

*(in thousands)*

| Revenues: | For the Three Months Ended September 30, 2020 | 2019 | Variance | For the Nine Months Ended September 30, 2020 | 2019 | Variance |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Commissions and fees | $65,843 | $38,383 | $27,460 | $171,270 | $101,280 | $69,990 |
| Operating expenses: |  |  |  |  |  |  |
| Commissions, employee compensation and benefits | 48,469 | 26,788 | 21,681 | 122,280 | 67,068 | 55,212 |
| Other operating expenses | 12,146 | 6,320 | 5,826 | 30,577 | 16,711 | 13,866 |
| Amortization expense | 5,185 | 3,082 | 2,103 | 13,231 | 6,793 | 6,438 |
| Change in fair value of contingent consideration | 6,455 | 535 | 5,920 | 12,697 | (3,222) | 15,919 |
| Depreciation expense | 258 | 184 | 74 | 663 | 460 | 203 |
| Total operating expenses | 72,513 | 36,909 | 35,604 | 179,448 | 87,810 | 91,638 |
| Operating income (loss) | (6,670) | 1,474 | (8,144) | (8,178) | 13,470 | (21,648) |
| Other expense: |  |  |  |  |  |  |
| Interest expense, net | (922) | (3,785) | 2,863 | (2,554) | (8,998) | 6,444 |
| Other income (expense) | (23) | 5 | (28) | (23) | 5 | (28) |
| Total other expense | (945) | (3,780) | 2,835 | (2,577) | (8,993) | 6,416 |
| Income (loss) before income taxes | (7,615) | (2,306) | (5,309) | (10,755) | 4,477 | (15,232) |
| Income tax provision | — | — | — | 12 | — | 12 |
| Net income (loss) | (7,615) | (2,306) | (5,309) | (10,767) | 4,477 | (15,244) |
| Less: net income (loss) attributable to noncontrolling interests | (4,347) | (2,306) | (2,041) | (5,379) | 4,477 | (9,856) |
| Net loss attributable to BRP Group, Inc. | $(3,268) | $— | $(3,268) | $(5,388) | $— | $(5,388) |

### Commissions and Fees

We earn commissions and fees by facilitating the arrangement between Insurance Company Partners and individuals or businesses for the carrier to provide insurance to the insured party. Our commissions and fees are usually a percentage of the premium paid by the insured and generally depends on the type of insurance, the particular Insurance Company Partner and the nature of the services provided. Under certain arrangements with clients, we earn pre-negotiated service fees in lieu of commissions. Additionally, we may also receive from Insurance Company Partners a profit-sharing commission, or straight override, which represent forms of variable consideration associated with the placement of coverage and are based primarily on underwriting results, but may also contain considerations for volume, growth or retention.

Commissions and fees increased by $27.5 million and $70.0 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. This increase was related to amounts attributable to Partners acquired during 2019 and 2020 prior to their having reached the twelve-month owned mark (such amounts, the “Partnership Contribution”) and organic growth. The Partnership Contribution accounted for $19.6 million and $54.6 million of the increase to commissions and fees for the quarter and year-to-date periods, respectively, and organic growth accounted for $7.8 million and $15.4 million, respectively.

### Major Sources of Commissions and Fees

The following table sets forth our commissions and fees by major source by amount for the periods indicated:

*(in thousands)*

|  | For the Three Months Ended September 30, 2020 | 2019 | Variance | For the Nine Months Ended September 30, 2020 | 2019 | Variance |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Direct bill revenue | $26,996 | $17,664 | $9,332 | $77,535 | $53,258 | $24,277 |
| Agency bill revenue | 28,130 | 14,253 | 13,877 | 64,815 | 31,084 | 33,731 |
| Profit-sharing revenue | 3,535 | 1,587 | 1,948 | 11,285 | 7,877 | 3,408 |
| Policy fee and installment fee revenue | 4,051 | 2,719 | 1,332 | 11,086 | 5,112 | 5,974 |
| Consulting and service fee revenue | 720 | 1,111 | (391) | 2,228 | 2,337 | (109) |
| Other income | 2,411 | 1,049 | 1,362 | 4,321 | 1,612 | 2,709 |
| Total commissions and fees | $65,843 | $38,383 | $27,460 | $171,270 | $101,280 | $69,990 |

Direct bill revenue represents commission revenue earned by providing insurance placement services to clients, primarily for private risk management, commercial risk management, employee benefits and Medicare insurance types. Direct bill revenue increased by $9.3 million and $24.3 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. The Partnership Contribution accounted for $9.2 million and $21.3 million of the increase to direct bill revenue for the quarter and year-to-date periods, respectively. Organic growth for direct bill revenue was $0.1 million and $3.0 million for the quarter and year-to-date periods, respectively. Organic growth for direct bill revenue was negatively impacted by $0.2 million for the year-to-date period as a result of incremental cancellation reserves related to COVID-19.

Agency bill revenue primarily represents commission revenue earned by providing insurance placement services to clients wherein we act as an agent on behalf of the Client. Agency bill revenue increased by $13.9 million and $33.7 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. The Partnership Contribution accounted for $7.8 million and $24.0 million of the increase to agency bill revenue for the quarter and year-to-date periods, respectively. Organic growth for agency bill revenue was $6.1 million and $9.7 million for the quarter and year-to-date periods, respectively.

Profit-sharing revenue represents bonus-type or contingent revenue that is earned by us as a sales incentive provided by certain Insurance Company Partners. Profit-sharing revenue increased by $1.9 million and $3.4 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. The Partnership Contribution accounted for $1.2 million and $3.2 million of the increase to profit-sharing revenue for the quarter and year-to-date periods, respectively. Profit-sharing revenue generated by legacy businesses was flat for the quarter and year-to-date periods, respectively. Profit-sharing revenue for the year-to-date period was affected by expected higher loss ratios in our Middle Market and MainStreet Operating Groups during the first half of 2020 and decreased underwriting in the Florida market by some of our Insurance Company Partners. We expect that rate pressure in the Florida market will increase base commissions and fees towards the end of 2020 and into 2021, but that profit-sharing revenue will continue to be challenged by disruption in the Florida personal lines market.

Policy fee and installment fee revenue represents revenue earned for acting in the capacity of an MGA and providing payment processing and services and other administrative functions on behalf of Insurance Company Partners. Policy fee and installment fee revenue increased by $1.3 million and $6.0 million during the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively, from our “MGA of the Future,” which was acquired April 1, 2019 and resides in our Specialty Operating Group.

### Commissions, Employee Compensation and Benefits

Commissions, employee compensation and benefits is our largest expense. It consists of (a) base compensation comprising salary, bonuses and benefits paid and payable to Colleagues, commissions paid to Colleagues and outside commissions paid to others; and (b) equity-based compensation associated with the grants of restricted interest awards to senior management, Risk Advisors and executives. We expect to continue to experience a general rise in commissions, employee compensation and benefits expense commensurate with expected growth in our sales and headcount and as a result of increasing employee compensation related to ongoing public company costs. We operate in competitive markets for human capital and need to maintain competitive compensation levels as we expand geographically and create new products and services.

Our compensation arrangements with our employees contain significant bonus or commission components driven by the results of our operations. Therefore, as we grow commissions and fees, we expect compensation costs to rise.

Commissions, employee compensation and benefits expenses increased by $21.7 million and $55.2 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. The Partnership Contribution accounted for $13.8 million and $36.0 million of the increase to commissions, employee compensation and benefits for the quarter and year-to-date periods, respectively. In addition, we had increased compensation for the quarter and year-to-date periods of $2.2 million and $4.6 million, respectively, as a result of 2019 and 2020 hiring for new roles necessary as a public company and to support our growth and $1.9 million and $4.6 million, respectively, related to share-based compensation expense.

### Other Operating Expenses

Other operating expenses include travel, accounting, legal and other professional fees, placement fees, rent, office expenses, depreciation and other costs associated with our operations. Our occupancy-related costs and professional services expenses, in particular, generally increase or decrease in relative proportion to the number of our employees and the overall size and scale of our business operations. In addition, we have invested in the expansion of our Tampa offices to accommodate our growth plans, which has resulted in an increase to rent expense beginning in April 2020. Certain corporate expenses are allocated to the Operating Groups.

Other operating expenses increased by $5.8 million and $13.9 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. These increases were primarily attributable to operating expenses such as additional rent and increased software costs, professional fees, and other expenses. The Partnership Contribution accounted for $1.5 million and $4.7 million of the increase to other operating expenses for the quarter and year-to-date periods, respectively. Additionally, we had public company costs of $0.8 million and $2.3 million for the quarter and year-to-date periods, respectively, and higher professional fees related to being a public company.

### Amortization Expense

Amortization expense increased by $2.1 million and $6.4 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively. These increases were driven by amortization related to Partners acquired over the past year, including $2.1 million and $4.1 million related to intangible assets capitalized in connection with Partners acquired during 2020 for the quarter and year-to-date periods, respectively, and $2.5 million related to intangible assets capitalized in connection with Partners acquired during 2019 for the year-to-date period.

### Change in Fair Value of Contingent Consideration

Change in fair value of contingent consideration was $6.5 million for the three months ended September 30, 2020 as compared to $0.5 million for the same period of 2019. The change in fair value of contingent consideration results from fluctuations in the value of the relevant measurement basis, normally revenue or EBITDA, of our Partners. The expense recorded for the third quarter of 2020 related primarily to higher estimates for the contingent earnout liabilities of three Partners during the third quarter of 2020 related to growth of their business during the period under consolidation, offset in part by a decrease in estimate for one Partner.

Change in fair value of contingent consideration was $12.7 million for the nine months ended September 30, 2020 as compared to $(3.2) million for the same period of 2019. The expense recorded for the year-to-date period of 2020 related primarily to higher estimates for the contingent earnout liabilities of three Partners related to growth of their business during the period under consolidation, offset in part by a decrease in estimate for one Partner. The expense recorded for the year-to-date period of 2019 related primarily to lower estimates for the contingent earnout liabilities of three Partners, offset in part by an increase in estimate for one Partner.

### Interest Expense, Net

Interest expense, net decreased by $2.9 million and $6.4 million for the three and nine months ended September 30, 2020 as compared to the same periods of 2019, respectively, resulting from a significantly lower interest rate and lower average borrowings under the Revolving Credit Commitment in effect during 2020 compared to credit facilities in place during the first nine months of 2019. The applicable interest rate on the Revolving Credit Commitment was 2.19% at September 30, 2020. We expect interest expense to increase under the New JPM Credit Agreement, which is discussed under the Liquidity and Capital Resources section below.

### NON-GAAP FINANCIAL MEASURES

Adjusted EBITDA, Adjusted EBITDA Margin, Organic Revenue, Organic Revenue Growth, Adjusted Net Income and Adjusted Diluted Earnings Per Share (“EPS”), are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for Organic Revenue and Organic Revenue Growth), net income (loss) (for Adjusted EBITDA and Adjusted EBITDA Margin) net income (loss) attributable to BRP Group, Inc. (for Adjusted Net Income) or diluted earnings (loss) per share (for Adjusted Diluted EPS), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to BRP Group, Inc. or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly these measures may not be comparable to similarly titled measures used by other companies.

Adjusted EBITDA eliminates the effects of financing, depreciation, amortization and change in fair value of contingent consideration. We define Adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related expenses related to Partnerships including severance, and certain non-recurring costs, including those related to raising capital. We believe that Adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.

Adjusted EBITDA Margin is Adjusted EBITDA divided by commissions and fees. Adjusted EBITDA Margin is a key metric used by management and our board of directors to assess our financial performance. We believe that Adjusted EBITDA Margin is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that Adjusted EBITDA Margin is helpful in measuring profitability of operations on a consolidated level.

Adjusted EBITDA and Adjusted EBITDA Margin have important limitations as analytical tools. For example, Adjusted EBITDA and Adjusted EBITDA Margin:

- do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;
- do not reflect changes in, or cash requirements for, our working capital needs;
- do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;
- do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;
- do not reflect share-based compensation expense and other non-cash charges; and
- exclude certain tax payments that may represent a reduction in cash available to us.

We calculate Organic Revenue Growth based on commissions and fees for the relevant period by excluding the first twelve months of commissions and fees generated from new Partners. Organic Revenue Growth is the change in Organic Revenue period-to-period, with prior period results adjusted for Organic Revenues that were excluded in the prior period because the relevant Partners had not yet reached the twelve-month owned mark, but which have reached the twelve-month owned mark in the current period. For example, revenues from a Partner acquired on June 1, 2019 are excluded from Organic Revenue for 2019. However, after June 1, 2020, results from June 1, 2019 to December 31, 2019 for such Partners are compared to results from June 1, 2020 to December 31, 2020 for purposes of calculating Organic Revenue Growth in 2020. Organic Revenue Growth is a key metric used by management and our board of directors to assess our financial performance. We believe that Organic Revenue and Organic Revenue Growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.

Adjusted Net Income is presented for the purpose of calculating Adjusted Diluted EPS. We define Adjusted Net Income as net income (loss) attributable to BRP Group, Inc. adjusted for amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related expenses related to Partnerships including severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments.

Adjusted Diluted EPS measures our per share earnings excluding certain expenses as discussed above and assuming all shares of Class B common stock were exchanged for Class A common stock. Adjusted Diluted EPS is calculated as Adjusted Net Income divided by adjusted dilutive weighted-average shares outstanding. We believe Adjusted Diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.

### Adjusted EBITDA and Adjusted EBITDA Margin

The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net income (loss), which we consider to be the most directly comparable GAAP financial measure to Adjusted EBITDA and Adjusted EBITDA Margin:

*(in thousands, except percentages)*

|  | For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Commissions and fees | $65,843 | $38,383 | $171,270 | $101,280 |
| Net income (loss) | $(7,615) | $(2,306) | $(10,767) | $4,477 |
| Adjustments to net income (loss): |  |  |  |  |
| Amortization expense | 5,185 | 3,082 | 13,231 | 6,793 |
| Change in fair value of contingent consideration | 6,455 | 535 | 12,697 | (3,222) |
| Share-based compensation | 2,240 | 382 | 5,357 | 773 |
| Interest expense, net | 922 | 3,785 | 2,554 | 8,998 |
| Depreciation expense | 258 | 184 | 663 | 460 |
| Transaction-related Partnership expenses | 2,904 | 500 | 6,772 | 1,535 |
| Severance related to Partnership activity | (324) | — | 89 | 300 |
| Capital related expenses | — | 1,124 | 1,000 | 2,214 |
| Income tax provision | — | — | 12 | — |
| Other | 899 | 92 | 1,733 | 391 |
| Adjusted EBITDA (1) | $10,924 | $7,378 | $33,341 | $22,719 |
| Adjusted EBITDA Margin | 17% | 19% | 19% | 22% |

(1) Adjusted EBITDA for the nine months ended September 30, 2019 is higher than the sum of Adjusted EBITDA for the first three quarters of 2019 as disclosed in our Quarterly Reports on Form 10-Q filed in 2020 as a result of rounding numbers in the prior periods.

### Organic Revenue and Organic Revenue Growth

The following table reconciles Organic Revenue to commissions and fees, which we consider to be the most directly comparable GAAP financial measure to Organic Revenue:

*(in thousands, except percentages)*

|  | For the Three Months Ended September 30, 2020 | 2019 | For the Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Commissions and fees | $65,843 | $38,383 | $171,270 | $101,280 |
| Partnership commissions and fees (1) | (19,637) | (17,520) | (54,569) | (36,749) |
| Organic Revenue | $46,206 | $20,863 | $116,701 | $64,531 |
| Organic Revenue Growth (2) | $7,809 | $2,297 | $15,393 | $5,479 |
| Organic Revenue Growth % (2) | 20% | 12% | 15% | 9% |

(1) Includes the first twelve months of such commissions and fees generated from newly acquired Partners.

(2) Organic Revenue for the three and nine months ended September 30, 2019 used to calculate Organic Revenue Growth for the three and nine months ended September 30, 2020 was $38.4 million and $101.3 million, which is adjusted to reflect revenues from Partnerships that reached the twelve-month owned mark during the three and nine months ended September 30, 2020.

### Adjusted Net Income and Adjusted Diluted EPS

The following table reconciles Adjusted Net Income to net income (loss) attributable to BRP Group, Inc. and reconciles Adjusted Diluted EPS to diluted loss per share attributable to BRP Group, Inc. Class A common stock:

*(in thousands, except per share data)*

|  | For the Three Months Ended September 30, 2020 | For the Nine Months Ended September 30, 2020 |
| --- | ---: | ---: |
| Net loss attributable to BRP Group, Inc. | $(3,268) | $(5,388) |
| Net loss attributable to noncontrolling interests | (4,347) | (5,379) |
| Amortization expense | 5,185 | 13,231 |
| Change in fair value of contingent consideration | 6,455 | 12,697 |
| Share-based compensation | 2,240 | 5,357 |
| Transaction-related Partnership expenses | 2,904 | 6,772 |
| Capital related expenses | — | 1,000 |
| Amortization of deferred financing costs | 189 | 384 |
| Severance related to Partnership activity | (324) | 89 |
| Other | 899 | 1,733 |
| Adjusted pre-tax income | 9,933 | 30,496 |
| Adjusted income taxes (1) | 983 | 3,019 |
| Adjusted Net Income | $8,950 | $27,477 |
| Weighted-average shares of Class A common stock outstanding - diluted | 33,098 | 24,371 |
| Dilutive effect of unvested restricted shares of Class A common stock | 759 | 483 |
| Exchange of Class B shares (2) | 45,288 | 44,767 |
| Adjusted dilutive weighted-average shares outstanding | 79,145 | 69,621 |
| Adjusted Diluted EPS | $0.11 | $0.39 |
| Diluted loss per share | $(0.10) | $(0.22) |
| Effect of exchange of Class B shares and net loss attributable to noncontrolling interests per share | — | 0.07 |
| Other adjustments to net loss per share | 0.22 | 0.58 |
| Adjusted income taxes per share | (0.01) | (0.04) |
| Adjusted Diluted EPS | $0.11 | $0.39 |

(1) Represents corporate income taxes at assumed effective tax rate of 9.9% applied to adjusted pre-tax income.

(2) Assumes the full exchange of Class B shares for Class A common stock pursuant to the Amended LLC Agreement.

### RESULTS OF OPERATIONS BY OPERATING GROUP

### Commissions and Fees

In the Middle Market, MainStreet and Specialty Operating Groups, the Company generates commissions and fees from insurance placement under both agency bill and direct bill arrangements. In addition, the Company generates profit-sharing income in each of those segments based on either the underlying Book of Business or performance, such as loss ratios. In the Middle Market Operating Group only, the Company generates fees from service fee and consulting arrangements. Service fee arrangements are in place with certain customers in lieu of commission arrangements.

In the Medicare Operating Group, BRP generates commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with the Company’s Insurance Company Partners.

The following table sets forth our commissions and fees by Operating Group by amount and as a percentage of our commissions and fees:

*Commissions and Fees by Operating Group (in thousands)*

| Operating Group | For the Three Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $26,561 | 40% | $12,836 | 33% | $13,725 | 107% | $69,311 | 40% | $41,481 | 41% | $27,830 | 67% |
| Specialty | 27,486 | 42% | 16,732 | 44% | 10,754 | 64% | 64,358 | 38% | 32,497 | 32% | 31,861 | 98% |
| MainStreet | 7,905 | 12% | 6,642 | 17% | 1,263 | 19% | 23,917 | 14% | 18,942 | 19% | 4,975 | 26% |
| Medicare | 4,101 | 6% | 2,173 | 6% | 1,928 | 89% | 13,894 | 8% | 8,360 | 8% | 5,534 | 66% |
| Corporate and Other | (210) | —% | — | —% | (210) | —% | (210) | —% | — | —% | (210) | —% |
|  | $65,843 |  | $38,383 |  | $27,460 |  | $171,270 |  | $101,280 |  | $69,990 |  |

Commissions and fees increased across all Operating Groups for the three months ended September 30, 2020 as compared to the same period of 2019. The Partnership Contribution accounted for $12.3 million, $5.4 million and $1.6 million of the increase to commissions and fees in the Middle Market, Specialty and Medicare Operating Groups, respectively. The remaining variances across the Operating Groups are attributable to organic growth. Our Middle Market Operating Group is most likely to feel the impact of the pandemic should the economic contraction persist and businesses act to further reduce their workforces.

Commissions and fees increased across all Operating Groups for the nine months ended September 30, 2020 as compared to the same period of 2019. The Partnership Contribution accounted for $24.0 million, $21.8 million, $3.7 million and $5.3 million of the increase to commissions and fees in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively. The remaining variances across the Operating Groups are attributable to Organic Growth. Continued COVID-19 protocols, including social distancing, may reduce our Medicare agents' abilities to meet person-to-person in our normal venues, which could impact our ability to sell new business during the 2021 Annual Enrollment Period and our first quarter 2021 commissions and fees.

The Middle Market and MainStreet Operating Groups had poor loss trends in our Florida-based personal lines businesses and private risk business in the first half of 2020 in addition to decreased underwriting in the Florida market by our Insurance Company Partners. We expect rate pressure in the Florida market to increase base commissions and fees towards the end of 2020 and into 2021 for those Operating Groups; however, rate pressure may also negatively impact client retention in those periods.

Policies in force for Specialty’s MSI Partnership grew by 144,557, or 41%, to 500,301 at September 30, 2020 from 355,744 at September 30, 2019.

### Commissions, Employee Compensation and Benefits

The following table sets forth our commissions, employee compensation and benefits by Operating Group by amount and as a percentage of our commissions, employee compensation and benefits:

*Commissions, Employee Compensation and Benefits by Operating Group (in thousands)*

| Operating Group | For the Three Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $18,070 | 37% | $9,203 | 34% | $8,867 | 96% | $44,153 | 36% | $26,956 | 40% | $17,197 | 64% |
| Specialty | 19,993 | 41% | 11,836 | 44% | 8,157 | 69% | 48,124 | 39% | 23,694 | 35% | 24,430 | 103% |
| MainStreet | 4,496 | 9% | 3,915 | 15% | 581 | 15% | 13,268 | 11% | 10,284 | 15% | 2,984 | 29% |
| Medicare | 2,455 | 5% | 1,180 | 4% | 1,275 | 108% | 7,686 | 6% | 4,170 | 6% | 3,516 | 84% |
| Corporate and Other | 3,455 | 7% | 654 | 2% | 2,801 | n/m | 9,049 | 7% | 1,964 | 3% | 7,085 | n/m |
|  | $48,469 |  | $26,788 |  | $21,681 |  | $122,280 |  | $67,068 |  | $55,212 |  |

n/m not meaningful

Commissions, employee compensation and benefits expenses increased across all Operating Groups for the three months ended September 30, 2020 as compared to the same period of 2019. The Partnership Contribution accounted for $7.9 million, $4.4 million and $1.4 million of the increase to commissions, employee compensation and benefits expenses in the Middle Market, Specialty and Medicare Operating Groups, respectively. Commissions, employee compensation and benefits expenses also increased in the Middle Market, Specialty and MainStreet Operating Groups as a result of continued investments in Growth Services to support our growth, which costs are primarily allocated among the Operating Groups.

Commissions, employee compensation and benefits expenses increased across all Operating Groups for the nine months ended September 30, 2020 as compared to the same period of 2019. The Partnership Contribution accounted for $14.6 million, $16.0 million, $1.8 million and $3.6 million of the increase to commissions, employee compensation and benefits expenses in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively. Commissions, employee compensation and benefits expenses also increased across the Middle Market, Specialty and MainStreet Operating Groups as a result of continued investments in Growth Services to support our growth, which costs are primarily allocated among the Operating Groups.

Commissions, employee compensation and benefits expenses for Corporate and Other increased as a result of hiring new roles necessary as a public company and due to $1.9 million and $4.6 million of additional share-based compensation expense incurred during the quarter and year-to-date periods, respectively.

### Other Operating Expenses

The following table sets forth our other operating expenses by Operating Group by amount and as a percentage of our other operating expenses:

*Other Operating Expenses by Operating Group (in thousands)*

| Operating Group | For the Three Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $4,046 | 33% | $2,257 | 36% | $1,789 | 79% | $9,665 | 32% | $6,254 | 37% | $3,411 | 55% |
| Specialty | 1,658 | 14% | 848 | 13% | 810 | 96% | 4,454 | 15% | 2,256 | 14% | 2,198 | 97% |
| MainStreet | 1,226 | 10% | 1,014 | 16% | 212 | 21% | 3,233 | 11% | 2,865 | 17% | 368 | 13% |
| Medicare | 952 | 8% | 505 | 8% | 447 | 89% | 2,739 | 9% | 1,390 | 8% | 1,349 | 97% |
| Corporate and Other | 4,264 | 35% | 1,696 | 27% | 2,568 | 151% | 10,486 | 34% | 3,946 | 24% | 6,540 | 166% |
|  | $12,146 |  | $6,320 |  | $5,826 |  | $30,577 |  | $16,711 |  | $13,866 |  |

37

Other operating expenses increased across all Operating Groups for the three months ended September 30, 2020 as compared to the same period of 2019. The Partnership Contribution accounted for $1.0 million and $0.4 million of the increase to other operating expenses in the Middle Market and Medicare Operating Groups, respectively.

Other operating expenses increased across all Operating Groups for the nine months ended September 30, 2020 as compared to the same period of 2019. The Partnership Contribution accounted for $2.5 million, $1.1 million, $0.2 million and $0.9 million other operating expenses in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively.

Other operating expenses in Corporate and Other, including professional fees, insurance, colleague education, travel and dues and subscriptions, increased primarily as a result of being a public company and an increased level of partnership activity during 2020.

### Amortization Expense

The following table sets forth our amortization by Operating Group by amount and as a percentage of our amortization:

*Amortization Expense by Operating Group (in thousands)*

| Operating Group | For the Three Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $2,120 | 41% | $552 | 18% | $1,568 | 284% | $4,075 | 31% | $1,349 | 20% | $2,726 | 202% |
| Specialty | 2,331 | 45% | 2,036 | 66% | 295 | 14% | 7,022 | 53% | 4,339 | 64% | 2,683 | 62% |
| MainStreet | 431 | 8% | 364 | 12% | 67 | 18% | 1,307 | 10% | 749 | 11% | 558 | 74% |
| Medicare | 303 | 6% | 96 | 3% | 207 | 216% | 819 | 6% | 286 | 4% | 533 | 186% |
| Corporate and Other | — | —% | 34 | 1% | (34) | (100)% | 8 | —% | 70 | 1% | (62) | (89)% |
|  | $5,185 |  | $3,082 |  | $2,103 |  | $13,231 |  | $6,793 |  | $6,438 |  |

Amortization expense increased across all Operating Groups for the three months ended September 30, 2020 as compared to the same period of 2019. These increases were driven by amortization related to Partners acquired over the past year, including $1.6 million, $0.3 million and $0.2 million related to intangible assets capitalized in connection with Partners acquired during 2020 in the Middle Market, Specialty and Medicare Operating Groups, respectively.

Amortization expense increased across all Operating Groups for the nine months ended September 30, 2020 as compared to the same period of 2019. These increases were driven by amortization related to Partners acquired over the past year, including $2.6 million, $1.0 million and $0.5 million related to intangible assets capitalized in connection with Partners acquired during 2020 in the Middle Market, Specialty and Medicare Operating Groups, respectively, and $0.2 million, $1.8 million and $0.5 million related to intangible assets capitalized in connection with Partners acquired during 2019 in the Middle Market, Specialty and MainStreet Operating Groups, respectively.

### Change in Fair Value of Contingent Consideration

The following table sets forth our change in fair value of contingent consideration by Operating Group by amount and as a percentage of our change in fair value of contingent consideration:

*Change in Fair Value of Contingent Consideration by Operating Group (in thousands)*

| Operating Group | For the Three Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2020 Amount | Percent of Business | 2019 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $1,056 | 16% | $445 | 83% | $611 | 137% | $(666) | (5)% | $(3,789) | 118% | $3,123 | (82)% |
| Specialty | 4,732 | 73% | (199) | (37)% | 4,931 | n/m | 10,850 | 85% | 578 | (18)% | 10,272 | n/m |
| MainStreet | 501 | 8% | 289 | 54% | 212 | 73% | 2,555 | 20% | 320 | (10)% | 2,235 | n/m |
| Medicare | 166 | 3% | — | —% | 166 | —% | (42) | —% | (331) | 10% | 289 | (87)% |
|  | $6,455 |  | $535 |  | $5,920 |  | $12,697 |  | $(3,222) |  | $15,919 |  |

n/m not meaningful

The change in fair value of contingent consideration results from fluctuations in the value of the relevant measurement basis, normally revenue or EBITDA of our Partners. The Specialty Operating Group recorded a significant expense during the third quarter of 2020 primarily as a result of a higher estimate for the contingent consideration liabilities of our MSI Partner related to growth of the business.

The Specialty and MainStreet Operating Groups recorded significant expenses during the nine months ended September 30, 2020 primarily as a result of higher estimates for the contingent consideration liabilities of the MSI and Foundation Insurance Partners, respectively, related to growth of the businesses.

### LIQUIDITY AND CAPITAL RESOURCES

Our primary liquidity needs for the foreseeable future will include cash to (i) provide capital to facilitate the organic growth of our business and to fund future Partnerships, (ii) pay operating expenses, including cash compensation to our employees and expenses related to being a public company, (iii) make payments under the Tax Receivable Agreement, (iv) pay interest and principal due on borrowings under the New JPM Credit Agreement (as defined below), (v) pay contingent earnout liabilities, and (vi) pay income taxes. We have historically financed our operations and funded our debt service through the sale of our insurance products and services. In addition, we financed significant cash needs to fund growth through the acquisition of Partners through debt and equity financing.

On June 29, 2020, we completed a public offering of 13,225,000 shares of our Class A common stock, including 1,725,000 shares sold pursuant to the underwriters’ over-allotment option. The shares were sold at an offering price of $13.25 per share for net proceeds of $166.5 million after deducting underwriting discounts and commissions of $7.9 million and offering expenses of $798,000.

At September 30, 2020, our cash and cash equivalents were $50.2 million. We believe that our cash and cash equivalents, cash flow from operations and available borrowings under the New JPM Credit Agreement (as defined below) will be sufficient to fund our working capital and meet our commitments for the foreseeable future. However, we expect that we will require additional funding to continue to execute on our Partnership strategy. Such funding could include the incurrence of additional debt or the issuance of equity. Additional funds may not be available on a timely basis, on favorable terms, or at all, and such funds, if raised, may not be sufficient to enable us to continue to implement our long-term Partnership strategy. If we are not able to raise funds when needed, we could be forced to delay or reduce the number of Partnerships that we complete.

See Part II, Item 1A. “Risk Factors - The ongoing novel coronavirus (COVID-19) pandemic could result in declines in business and increases in claims that could adversely affect our business, financial condition and results of operations” in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020.

### JPMorgan Credit Agreement

As of September 30, 2020, we had an aggregate borrowing capacity of $400.0 million under the Revolving Credit Commitment of the Old JPM Credit Agreement, which matures on September 23, 2024 and of which no more than $65.0 million is available for working capital purposes and the entirety of which is available to fund acquisitions permitted under the Old JPM Credit Agreement. The outstanding balance of the Revolving Credit Commitment was $101.0 million at September 30, 2020.

The interest rate of the Revolving Credit Commitment is based on, depending on the type of loan, the Eurodollar rate or the Alternative Base Rate, plus, in each case, a margin based on Total Leverage Ratio (as defined in the Old JPM Credit Agreement), as set forth in the pricing grid below, provided that under no circumstances will the LIBO Rate (as defined in the Old JPM Credit Agreement) used in the determination of the Eurodollar rate be less than 0.00% or the Alternate Base Rate be less than 1.00%:

| Total Net Leverage Ratio | Applicable Margin for Eurodollar Loans | Applicable Margin for Alternate Base Rate Loans |
| --- | --- | --- |
| \< 2.50x | 200 bps | 100 bps |
| ≥ 2.50x \< 3.00x | 225 bps | 125 bps |
| ≥ 3.00x \< 3.75x | 250 bps | 150 bps |
| ≥ 3.75x | 300 bps | 200 bps |

At September 30, 2020 and December 31, 2019, the variable rate in effect for the Old JPM Credit Agreement was the London Interbank Offered Rate (“LIBOR”) due to a pricing option and the applicable interest rate on the Revolving Credit Commitment was 2.19% and 3.81%, respectively.

On October 14, 2020, we entered into the New JPM Credit Agreement with JPMorgan Chase Bank, N.A., to provide new senior secured credit facilities in an aggregate principal amount of $800.0 million. The amount consists of (i) a new term loan facility in the principal amount of $400.0 million maturing in 2027 (the “Term Loan B”) and (ii) a new revolving credit facility with commitments in an aggregate principal amount of $400.0 million maturing in 2025 (the “Revolving Facility”). We utilized a portion of the proceeds from the Term Loan B to repay in full our obligations under the Old JPM Credit Agreement and concurrently terminated the existing agreement. The Revolving Facility and the remaining proceeds of the Term Loan B are available to finance working capital needs and for other general corporate purposes of BRP and certain of its subsidiaries (including acquisitions and other investments permitted under the New JPM Credit Agreement.

Interest rates under the Revolving Facility will remain the same as the interest rates under the Old JPM Credit Agreement, with borrowings accruing interest on amounts drawn at LIBOR plus 200 basis points (“bps”) to LIBOR plus 300 bps based on total net leverage ratio. The Term Loan B will bear interest at LIBOR plus 400 bps. BRP will pay a letter of credit fee equal to the margin then in effect with respect to LIBOR loans under the Revolving Facility multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee and any customary documentary and processing charges for any letter of credit issued under the New JPM Credit Agreement.

The outstanding principal balance of the Term Loan B is required to be repaid in equal quarterly installments equal to 0.25% of the original principal amount of the Term Loan B beginning with the fiscal quarter ending December 31, 2020, the balance of which is due at maturity. The Revolving Facility is not subject to amortization.

The Revolving Facility and the Term Loan B are collateralized by a first priority lien on substantially all the assets of BRP, including a pledge of all equity securities of certain of its subsidiaries. The New JPM Credit Agreement contains covenants that, among other things, restrict our ability to make certain restricted payments, incur additional debt, engage in certain asset sales, mergers, acquisitions or similar transactions, create liens on assets, engage in certain transactions with affiliates, change our business, make certain investments or restrict BRP’s ability to make dividends or other distributions to BRP Group. In addition, the New JPM Credit Agreement contains financial covenants requiring us to maintain our Total First Lien Net Leverage Ratio (as defined in the New JPM Credit Agreement) at or below 5.00 to 1.00 and Debt Service Coverage Ratio (as defined in the New JPM Credit Agreement) at or above 2.25 to 1.00.

### Contractual Obligations

The following table represents our contractual obligations, aggregated by type, at September 30, 2020, adjusted to reflect debt obligations under the New JPM Credit Agreement:

*(in thousands)*

|  | Payments Due by Period Total | Less than 1 year | 1-3 years | 3-5 years | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating leases (1) | $46,394 | $7,139 | $12,773 | $10,476 | $16,006 |
| Debt obligations payable (2) | 517,892 | 16,750 | 33,500 | 33,500 | 434,142 |
| Maximum future acquisition contingency payments (3) | 233,574 | 57,572 | 164,902 | 11,100 | — |
| Total | $797,860 | $81,461 | $211,175 | $55,076 | $450,148 |

(1) The Company leases facilities and equipment under noncancelable operating leases. Rent expense was $4.6 million and $3.0 million for the nine months ended September 30, 2020 and 2019, respectively.

(2) Represents scheduled debt obligations and estimated interest payments under the New JPM Credit Agreement.

(3) Includes $85.4 million of current and noncurrent estimated contingent earnout liabilities at September 30, 2020.

### Tax Receivable Agreement

We expect to obtain an increase in our share of our tax basis of the assets when BRP’s LLC Units are redeemed or exchanged for shares of BRP Group’s Class A common stock. This increase in tax basis may have the effect of reducing the future amounts paid to various tax authorities. The increase in tax basis may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.

We entered into a Tax Receivable Agreement on October 28, 2019 (the “Tax Receivable Agreement”) that provides for the payment by us to the parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that we actually realize as a result of (i) any increase in tax basis in BRP Group’s assets and (ii) tax benefits related to imputed interest deemed arising as a result of payments made under the tax receivable agreement.

During the nine months ended September 30, 2020, we redeemed and repurchased LLC Units and shares of Class B common stock, which triggered an increase in BRP Group’s tax basis but did not result in a tax benefit to the LLC Unit holders.

### SOURCES AND USES OF CASH

The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:

*(in thousands)*

|  | For the Nine Months Ended September 30, 2020 | 2019 | Variance |
| --- | ---: | ---: | ---: |
| Net cash provided by operating activities | $30,771 | $14,569 | $16,202 |
| Net cash used in investing activities | (235,233) | (101,822) | (133,411) |
| Net cash provided by financing activities | 191,389 | 96,768 | 94,621 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | (13,073) | 9,515 | (22,588) |
| Cash and cash equivalents and restricted cash at beginning of period | 71,071 | 7,995 | 63,076 |
| Cash and cash equivalents and restricted cash at end of period | $57,998 | $17,510 | $40,488 |

### Operating Activities

The primary sources and uses of cash for operating activities are net income adjusted for non-cash items and changes in assets and liabilities, or operating working capital. Net cash provided by operating activities increased $16.2 million for the nine months ended September 30, 2020 as compared to the same period of 2019 driven by a net increase in net income (loss) adjusted for noncash items, partially offset by losses in revenues from profit-sharing and fees, and higher accounts payable, accrued expenses and other current liabilities balances, offset in part by a higher premiums, commissions and fees receivable balance.

### Investing Activities

The primary sources and uses of cash for investing activities relate to cash consideration paid to fund Partnerships and other investments, as well as capital expenditures. Net cash used in investing activities increased $133.4 million for the nine months ended September 30, 2020 as compared to the same period of 2019. Cash consideration paid to fund Partnerships increased $130.9 million as a result of an increase in the number of Partnerships and other asset acquisitions we completed during the first nine months of 2020 compared to the same period of 2019.

### Financing Activities

The primary sources and uses of cash for financing activities relate to the issuance of our Class A common stock, borrowings from and repayment to our credit agreements, payment of debt issuance costs, payment of contingent and guaranteed earnout consideration, distributions and contributions, and other equity transactions. Net cash provided by financing activities increased $94.6 million for the nine months ended September 30, 2020 as compared to the same period of 2019. During 2020, we received net proceeds of $135.2 million from the public offering of our Class A common stock after deducting underwriting discounts and commissions, offering expenses and the repurchase of LLC Units from our Chairman and other founders. In addition, net borrowings on our credit facilities increased $57.5 million as a result of borrowings to fund the two Partnerships during the second quarter of 2020, offset in part by a repayment made with proceeds from our public offering.

### CRITICAL ACCOUNTING ESTIMATES

In preparing our financial statements in accordance with GAAP, we are required to make estimates and assumptions that affect the amounts of assets, liabilities, revenue, expenses, disclosure of contingent assets and liabilities and accompanying disclosures. We evaluate our estimates and assumptions on an ongoing basis. These estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances; although, actual results may differ from these estimates and assumptions. To the extent that there are differences between our estimates and actual results, our financial condition, results of operations and cash flows will be affected.

There have been no material changes in our critical accounting policies during the three months ended September 30, 2020 as compared to those disclosed in the Critical Accounting Estimates section under Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K filed with the SEC on March 24, 2020.

### EMERGING GROWTH COMPANY STATUS

We are an emerging growth company, as defined in the Jumpstart Our Business Startups (“JOBS”) Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period for the implementation of new or revised accounting standards. We have elected to use the extended transition period for complying with new or revised accounting standards and as a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates. We have also elected to take advantage of some of the reduced regulatory and reporting requirements of emerging growth companies pursuant to the JOBS Act, including not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and exemptions from the requirements of holding non-binding advisory votes on executive compensation and golden parachute payments, if applicable.

We may take advantage of these exemptions up until the last day of the fiscal year following the fifth anniversary of our initial public offering or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more than $1.07 billion in annual revenue, we have more than $700.0 million in market value of our stock held by non-affiliates (and we have been a public company for at least 12 months and have filed one annual report on Form 10-K) or we issue more than $1.0 billion of non-convertible debt securities over a three-year period.

### RECENT ACCOUNTING PRONOUNCEMENTS

Please refer to Note 1 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.

## Market risk

As filed, 2,983 characters.

Market risk is the potential loss arising from adverse changes in market rates and prices, such as premium amounts, interest rates and equity prices. We are exposed to market risk through our investments and borrowings under the Old JPM Credit Agreement.

Our invested assets are held primarily as cash and cash equivalents, restricted cash, certificates of deposit, U.S. treasury securities and professionally managed short duration fixed income funds. These investments are subject to interest rate risk. The fair values of our invested assets at September 30, 2020 and December 31, 2019 approximated their respective carrying values due to their short-term duration and therefore, such market risk is not considered to be material.

Insurance premium pricing has historically been cyclical, based on the underwriting capacity of the insurance industry and economic conditions. External events, such as terrorist attacks, man-made and natural disasters, can also have significant impacts on the insurance market. We use the terms ‘‘soft market’’ and ‘‘hard market’’ to describe the business cycles experienced by the industry. A soft market is an insurance market characterized by a period of declining premium rates, which can negatively affect commissions earned by insurance agents. A hard market is an insurance market characterized by a period of rising premium rates, which, absent other changes, can positively affect commissions earned by insurance agents.

We do not actively invest or trade in equity securities. In addition, we generally dispose of any significant equity securities received in conjunction with an acquisition shortly after the acquisition date.

At September 30, 2020, we had $101.0 million of borrowings outstanding under the Old JPM Credit Agreement, which bears interest on a floating basis tied to either the prime rate or one of various other variable rates as defined in the Old JPM Credit Agreement, and therefore is subject to changes in the associated interest expense. At September 30, 2020, the variable rate in effect for the Old JPM Credit Agreement was LIBOR. Based on an increase of 25 and 50 basis points in the LIBOR at September 30, 2020 and the balance outstanding at such time, our annual interest expense for the Old JPM Credit Agreement would have increased by $253,000 and $505,000, respectively.

Subsequent to September 30, 2020, we repaid our obligations under the Old JPM Credit Agreement and borrowed $400.0 million under the New JPM Credit Agreement. These borrowings bear interest on a floating basis tied to either the prime rate or one of various other variable rates as defined in the New JPM Credit Agreement. The variable rate currently in effect for the New JPM Credit Agreement is LIBOR. Assuming the New JPM Credit Agreement had been in effect at September 30, 2019, an increase of 25 and 50 basis points in the LIBOR would have increased our annual interest expense by $1.0 million and $2.0 million, respectively.

## Controls and procedures

As filed, 2,452 characters.

Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, because of the material weaknesses in internal control over financial reporting described in this report, our disclosure controls and procedures were not effective as of September 30, 2020.

We previously reported four material weaknesses in the design and operation of our internal control over financial reporting that were identified in connection with the audit of our fiscal year 2018 consolidated financial statements. A “material weakness” is defined under SEC rules as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls. The material weaknesses relate to (i) lack of sufficient number of personnel with the appropriate level of accounting knowledge, training and experience to appropriately analyze, record and disclose accounting matters timely and accurately; (ii) insufficient policies and procedures to achieve complete and accurate financial accounting, reporting and disclosures; (iii) insufficient policies and procedures to review, analyze, account for and disclose complex transactions; and (iv) failure to design and maintain controls over the operating effectiveness of information technology. During the quarter ended September 30, 2020, we continued the process of planning and implementing a number of steps to enhance our internal control over financial reporting and to address these material weaknesses. We have hired key personnel in the accounting department with technical accounting and financial reporting experience and have enhanced our internal review procedures during the financial statement close process. We are continuing to document and improve our processes, implement internal controls procedures and design and implement IT general computer controls. These material weaknesses still exist at September 30, 2020.

## Risk factors

As filed, 238 characters.

See the risk factors outlined under Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 24, 2020 and in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020 filed with the SEC on May 13, 2020.

Filed Nov 12, 2020.
Source: SEC EDGAR, the filing index for accession 0001781755-20-000076. Last ingested by Listed: Nov 10, 2026, 03:23 ET. No prices; not investment advice.
